Published in Clin Exp Allergy on July 01, 1994
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41
Asthma and the beta agonist debate. Thorax (1995) 0.85
Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years. Thorax (2001) 0.84
Oral vs inhaled asthma therapy. Pros, cons and combinations. Drugs (1996) 0.75
Risk of severe life threatening asthma. Thorax (1996) 0.75
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis (1990) 2.81
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27
Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25
Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19
Passive smoking and passive thinking. N Z Med J (1989) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Receptor-triggered membrane association of a model retroviral glycoprotein. Proc Natl Acad Sci U S A (1998) 1.91
House dust mite allergen (Der p 1) accumulation on new synthetic and feather pillows. Clin Exp Allergy (1999) 1.89
Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88
Defining asthma in epidemiological studies. Eur Respir J (1999) 1.88
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
House dust mite allergen in pillows. BMJ (1996) 1.83
Obesity and asthma in 11-12 year old New Zealand children in 1989 and 2000. Thorax (2005) 1.82
Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy (2007) 1.81
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
The ecological fallacy strikes back. J Epidemiol Community Health (2000) 1.79
Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77
Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J (2007) 1.64
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
The importance of housing characteristics in determining Der p 1 levels in carpets in New Zealand homes. Clin Exp Allergy (2001) 1.61
Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med (2004) 1.60
Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis (2013) 1.57
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J (1994) 1.57
Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56
Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy (2009) 1.55
Asthma in Maori people. N Z Med J (1992) 1.54
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol (2002) 1.49
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48
Preservatives in nebulizer solutions: risks without benefit. Pharmacotherapy (1998) 1.47
Environmental epidemiology: challenges and opportunities. Environ Health Perspect (2001) 1.47
Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine? J Epidemiol Community Health (2002) 1.46
Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
Selenium status and allergic disease in a cohort of New Zealand children. Clin Exp Allergy (2012) 1.45
Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer (1989) 1.43
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust (1990) 1.41